Summary of Significant Accounting Policies - Schedule of Fair Value Measurements (Details) - USD ($)	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Investments in equity securities, carrying value
Investments in equity securities		1,769,300
Convertible Series E Preferred Shares [Member] | Adhera Therapeutics [Member]
Investments in equity securities, carrying value
Investments in equity securities		1,769,300
Level 1 [Member]
Investments in equity securities
Level 1 [Member] | Convertible Series E Preferred Shares [Member] | Adhera Therapeutics [Member]
Investments in equity securities
Level 2 [Member]
Investments in equity securities
Level 2 [Member] | Convertible Series E Preferred Shares [Member] | Adhera Therapeutics [Member]
Investments in equity securities
Level 3 [Member]
Investments in equity securities		1,769,300	$ 1,769,300
Level 3 [Member] | Convertible Series E Preferred Shares [Member] | Adhera Therapeutics [Member]
Investments in equity securities		$ 1,769,300